A risk score based on baseline risk factors for predicting mortality in COVID-19 patients

Ze Chen, Jing Chen, Jianghua Zhou, Fang Lei, Feng Zhou, Juan‐Juan Qin, Xiao‐Jing Zhang, Lihua Zhu, Ye-Mao Liu, Haitao Wang, Mingming Chen, Yan-Ci Zhao, Jing Xie, Lijun Shen, Xiaohui Song, Xingyuan Zhang, Chengzhang Yang, Weifang Liu, Deliang Guo, Youqin Yan, Mingyu Liu, Weiming Mao, Li Liu, Ping Ye, Bing Xiao, Pengcheng Luo, Zixiong Zhang, Zhigang Lu, Junhai Wang, Haofeng Lu, Xigang Xia, Daihong Wang, Xiaofeng Liao, Gang Peng, Liang Liang, Jun Yang, Guohua Chen, Elena Azzolini, Alessio Aghemo, Michele Ciccarelli, Gianluigi Condorelli, Giulio Stefanini, Wei Xiang, Binghong Zhang, Xiaodong Huang, Jiahong Xia, Yufeng Yuan, Zhi‐Gang She, Jiao Guo, Yibin Wang, Peng Zhang, Hongliang LiFigshare 2021 · DOI · OpenAlex

Abstract

To develop a sensitive and clinically applicable risk assessment tool identifying coronavirus disease 2019 (COVID-19) patients with a high risk of mortality at hospital admission. This model would assist frontline clinicians in optimizing medical treatment with limited resources. 6,415 patients from seven hospitals in Wuhan city were assigned to the training and testing cohorts. A total of 6,351 patients from another three hospitals in Wuhan, 2,169 patients from outside of Wuhan, and 553 patients from Milan, Italy were assigned to three independent validation cohorts. A total of 64 candidate clinical variables at hospital admission were analyzed by random forest and least absolute shrinkage and selection operator (LASSO) analyses. Eight factors, namely, <b>O</b>xygen saturation, blood <b>U</b>rea nitrogen, <b>R</b>espiratory rate, admission before the date the national <b>M</b>aximum number of daily new cases was reached, <b>A</b>ge, <b>P</b>rocalcitonin, <b>C</b>-reactive protein (CRP), and absolute <b>N</b>eutrophil counts, were identified as having significant associations with mortality in COVID-19 patients. A composite score based on these eight risk factors, termed the OURMAPCN-score, predicted the risk of mortality among the COVID-19 patients, with a C-statistic of 0.92 (95% confidence interval [CI] 0.90-0.93). The hazard ratio for all-cause mortality between patients with OURMAPCN-score &gt;11 compared with those with scores ≤11 was 18.18 (95% CI 13.93-23.71; P &lt; 0.0001). The predictive performance, specificity, and sensitivity of the score were validated in three independent cohorts. The OURMAPCN score is a risk assessment tool to determine the mortality rate in COVID-19 patients based on a limited number of baseline parameters. This tool can assist physicians in optimizing the clinical management of COVID-19 patients with limited hospital resources.
BibTeX
@inproceedings{chen2021risk,
  author = {Ze Chen and Jing Chen and Jianghua Zhou and Fang Lei and Feng Zhou and Juan‐Juan Qin and Xiao‐Jing Zhang and Lihua Zhu and Ye-Mao Liu and Haitao Wang and Mingming Chen and Yan-Ci Zhao and Jing Xie and Lijun Shen and Xiaohui Song and Xingyuan Zhang and Chengzhang Yang and Weifang Liu and Xiao Zhang and Deliang Guo and Youqin Yan and Mingyu Liu and Weiming Mao and Li Liu and Ping Ye and Bing Xiao and Pengcheng Luo and Zixiong Zhang and Zhigang Lu and Junhai Wang and Haofeng Lu and Xigang Xia and Daihong Wang and Xiaofeng Liao and Gang Peng and Liang Liang and Jun Yang and Guohua Chen and Elena Azzolini and Alessio Aghemo and Michele Ciccarelli and Gianluigi Condorelli and Giulio Stefanini and Wei Xiang and Binghong Zhang and Xiaodong Huang and Jiahong Xia and Yufeng Yuan and Zhi‐Gang She and Jiao Guo and Yibin Wang and Peng Zhang and Hongliang Li},
  title = {{A risk score based on baseline risk factors for predicting mortality in COVID-19 patients}},
  booktitle = {Figshare},
  year = {2021},
  doi = {10.6084/m9.figshare.14233228.v1},
}

Loading related content...

Figure